Skip to main content
SpringerLink
Log in

Exercise Response of Patients with Coronary Artery Disease during Treatment with Isosorbide-5-Mononitrate and slow release Nifedipine

  • Conference paper
Mononitrate II

Part of the book series: International Boehringer Mannheim Symposia ((BOEHRINGER))

Abstract

The haemodynamic effects and antianginal efficacy of isosorbide-5-mononitrate (IS-5-MN) have been demonstrated in numerous controlled clinical studies [1–7]: 20 mg IS-5-MN exhibited an antianginal efficacy of at least 10.5 h [8].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stauch M, Grewe N, Nissen H (1975) Die Wirkung von 2- und 5-Isosorbidmononitrat auf das Belastungs-EKG von Patienten mit Koronarinsuffizienz. Verh Dtsch Ges Kreislaufforsch 41: 181–184

    Google Scholar 

  2. Stauch M, Grewe N (1980) Die Wirkung von Isosorbiddinitrat, Isosorbid-2- und -5-Mononitrat auf das Belastungs-EKG und auf die Hämodynamik während Vorhofstimulation bei Patienten mit Angina pectoris. In: Rudolph W, Schrey A (eds) Nitrate II. Urban and Schwarzenberg, Munich

    Google Scholar 

  3. Bödigheimer K, Nowak FG, Delius W (1981) Vergleichende invasive Untersuchung über die Wirkung von Isosorbid-5-Mononitrat und Isosorbiddinitrat bei chronischer Herzinsuffizienz. Med Welt 32, 14a: 543–547

    PubMed  Google Scholar 

  4. Reifart N, Reifart F, Kaltenbach M, Bussmann W-D (1981) Vergleich der antianginösen Wirksamkeit und Wirkdauer von oral verabreichtem Isosorbiddinitrat (ISDN), Isosorbid-2-Mononitrat (IS-2-MN) und Isosorbid-5-Mononitrat (IS-5-MN). Med Welt 32, 14a: 524–526

    PubMed  CAS  Google Scholar 

  5. Müller G, Häcker W, Schneider B (1983) Intra-individual comparison of the action of equal doses of isosorbide-5-endmononitrate, slow-release isosorbide dinitrate and placebo in patients with coronary heart disease. Klin Wochenschr 61: 409–416

    Article  PubMed  Google Scholar 

  6. Überbacher HJ, Glocke M, Abshagen U (1983) Langzeitverträglichkeit und koronartherapeutische Wirksamkeit von Isosorbid-5-Mononitrat — Offene Multicenter-Studie unter Praxisbedingungen mit ISMO. MMW 125, 4: 76–78

    Google Scholar 

  7. Überbacher HJ, Steinorth G, Glocke M, Abshagen U (1983) An open, long-term, multicentre study of the antianginal efficacy and safety of isosorbide-5-mononitrate at low doses in patients with coronary heart disease. Pharmatherapeutica 3, 5: 331–341

    PubMed  Google Scholar 

  8. Müller G, Überbacher HJ, Glocke M (1983) Koronartherapeutische Wirksamkeit von niedrig dosiertem IS-5-MN im Vergleich zur Kombination IS-5-MN + Metipranolol und Plazebo. Med Welt 34, 10: 321–327

    PubMed  Google Scholar 

  9. Schulz W (1983) Antianginöse Wirksamkeit des Kalziumantagonisten Nifedipin in Abhängigkeit vom Koronarbefall. Z Kardiol 72: 657–664

    PubMed  CAS  Google Scholar 

  10. Brügmann U (1982) Unterschiedliches Ansprechen von Patienten mit stabiler Belastungs-Angina-pectoris auf Nifedipin. Herz 7: 117

    PubMed  Google Scholar 

  11. Ebner F (1975) Nifedipin (Adalat) - Synopsis einer weltweiten klinischen Prüfung. Ther Ber 47: 204–213

    Google Scholar 

  12. Bidoggia H, Machado R (1976) Antianginal effect of Nifedipine in a double-blind cross-over trial. In: Jatene AD, Lichtlen PR (eds) 3rd International Adalat Symposium, Rio de Janeiro, Oct. 10–11, 1975. Excerpta Medica, Amsterdam, pp 226–232

    Google Scholar 

  13. Clark RE (1979) Reduction of consequences of ischemia and preservation of myocardium with nifedipine. Am J Cardiol 43: 361

    Google Scholar 

  14. Weisfeldt ML (1979) Nifedipine to preserve function during ischemia. Am J Cardiol 44: 842

    Article  PubMed  CAS  Google Scholar 

  15. Cyran J (1987) Kalziumantagonisten bei akutem Myocardinfarkt? Internist 28: 100

    PubMed  CAS  Google Scholar 

  16. Crea F (1986) Variability of results during repeated exercise stress testing in patients with stable angina pectoris: role of dynamic coronary flow reserve. Am Heart J 112, 2: 249

    Article  PubMed  CAS  Google Scholar 

  17. Becker HJ, Kaltenbach M, Werner H, Krehan L, Hopf R (1980) Dosis-Wirkungs-Relation von Kalzium-Antagonisten und Isosorbiddinitrat bei Patienten mit stabiler Angina pectoris. In: Fleckenstein A, Roskamm H (eds) In: Calcium-Antagonismus. Springer, Berlin Heidelberg New York

    Google Scholar 

  18. Lehmann EL (1975) Nonparametrics: statistical methods based on ranks. Holden-Day, San Francisco

    Google Scholar 

  19. Abshagen U, Spörl-Radun S (1981) First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man. Eur J Clin Pharmacol 19: 423–429

    Article  PubMed  CAS  Google Scholar 

  20. Abshagen U, Betzien G, Endele R, Kaufmann B (1981) Pharmacokinetics of intravenous and oral isosorbide-5-mononitrate. Eur J Clin Pharmacol 20: 269–275

    Article  PubMed  CAS  Google Scholar 

  21. Mannebach H, Ohlmeier H, von Möllendorff E, Gleichmann U, Abshagen U (1981) Steady state-Kinetik von Isosorbid-5-Mononitrate bei Patienten mit koronarer Herzkrankheit. Med Welt 32, 14a: 517–520

    PubMed  CAS  Google Scholar 

  22. Rämsch KD (1983) Pharmakokinetik verschiedener Darreichungsformen von Adalat. In: Erfahrungen mit Adalat in Klinik und Praxis. Perimed, p 19

    Google Scholar 

  23. Koch G, Fransson L, Karlegärd L, Sauer W, Überbacher H-J (1984) Double-blind comparison of the effects of nifedipine and isosorbide-5-mononitrate on the circulatory response to exercise, exercise tolerance and ST-segment depression in patients with ischemic heart disease. In: Cohn JN, Rittinghausen R (eds) Mononitrates. Springer, Berlin Heidelberg New York, p 245

    Google Scholar 

Download references

Authors
  1. A. Schmidt-Thrun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Mentzel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. British Heart Foundation, 102 Gloucester Place, London, W1H 4DH, UK

    D. G. Julian Prof. M.D. (Medical Director) (Medical Director)

  2. Clinical Research Boehringer Mannheim GmbH, Sandhofer Straße 116, 6800, Mannheim 31, Federal Republic of Germany

    R. Rittinghausen M.D. (Director) (Director)

  3. Cardiovascular Clinical Research Boehringer Mannheim GmbH, Sandhofer Straße 116, 6800, Mannheim 31, Federal Republic of Germany

    H. J. Überbacher M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schmidt-Thrun, A., Mentzel, W. (1987). Exercise Response of Patients with Coronary Artery Disease during Treatment with Isosorbide-5-Mononitrate and slow release Nifedipine. In: Julian, D.G., Rittinghausen, R., Überbacher, H.J. (eds) Mononitrate II. International Boehringer Mannheim Symposia. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72689-7_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72689-7_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-17832-3

  • Online ISBN: 978-3-642-72689-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation